Search results
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 3 months agoThe consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical...
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
Zacks via Yahoo Finance· 4 months agoInovio Pharma (INO) surges 134% in a month, mainly due to its plans to submit a regulatory...
Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors...
Simply Wall St. via Yahoo Finance· 1 year agoInovio Pharmaceuticals, Inc. (NASDAQ:INO) shareholders should be happy to see the share price up 11%...
INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up
Zacks via Yahoo Finance· 1 year agoINOVIA (INO) shares surge 12% in the after-market hours, when its drug for treating a rare...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Inovalis Real Estate Investment Trust (TSE:INO.UN) shareholders have earned a 3.6% CAGR over the...
Simply Wall St. via Yahoo Finance· 2 years agoIdeally, your overall portfolio should beat the market average. But in any portfolio, there will be...
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's...
Zacks via Yahoo Finance· 2 years agoInovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings...
Institutions along with individual investors who hold considerable shares inInovio Pharmaceuticals,...
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) can tell us which group is...
Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoInovio (INO) delivered earnings and revenue surprises of -53.33% and 264.65%, respectively, for the...
Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster
Benzinga via Yahoo Finance· 2 years agoInovio Pharmaceuticals Inc (NASDAQ: INO) discontinued its internally funded efforts to develop...